Kevin Varner, MD
Foot and Ankle Surgery · Houston, TXNPI 1891731303
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (54.4%), other and consulting fees — rather than concentrated in one kind of arrangement. Linvatec Corporation accounts for 63.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $509,719 and has fallen 84.4% since, to $79,285 in 2025. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $8041.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$665K
- In2bones USA, LLC$277K
- Stryker$102K
- Theramicro, Inc.$7K
- Vilex LLC$1K
- Ossur Americas, Inc.$257
- plus $726 from 9 others
What the payments were for
- Royalty or licence$572,55054%
- Consulting fees$15,2501%
- Speaking & faculty fees$5,0000%
- Travel & lodging$7,4201%
- Food & beverage$2,1760%
- Other$451,04843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 24 | $665,433 |
| In2bones USA, LLC | 24 | $276,924 |
| Stryker(2 entities) | 16 | $102,007 |
| Theramicro, Inc. | 8 | $6,678 |
| Vilex LLC | 5 | $1,419 |
| Ossur Americas, Inc. | 37 | $257 |
| Johnson & Johnson | 2 | $193 |
| Bioventus LLC | 6 | $132 |
| Acumed LLC | 2 | $123 |
| Trilliant Surgical LLC. | 1 | $97 |
| Radius Health, Inc. | 1 | $71 |
| Pacira Pharmaceuticals Incorporated | 2 | $52 |
| Vertex | 1 | $27 |
| Wound Management Technologies, Inc | 1 | $21 |
| Dynasplint Systems Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVENGER RADIAL HEAD, +4 STEMS$451,048
- 5MS$282,709
- FRACTURE AND CORRECTION COLAG 2$162,423
- CoLink$139,830
- CoLag$135,238
- COLINK AFX$83,952
- ORTHOLOC 3DI CROSSCHECK$52,612
- CROSSCHECK$49,395
- IN2BONES USA$46,020
- COLINK MINI$46,020
- COLINK MFX$13,855
- COLINK 2$10,422
- TekBrace Solo$6,678
- HINTERMANN$1,405
- NA$123
How this compares
$1,053,444 in reported general payments places this provider in the 95th percentile of 684 foot and ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 18 | $109 |
| Gabapentin | 18 | $103 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $76 |
| Meloxicam | 18 | $35 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Houston
- Sherman NaglerHouston$602K
- Abdul NurudeenHouston$404K
- Orlando RiveraHouston$384K
- Brian LepowHouston$309K
- Yueh LeeHouston$95K
- William GranberryHouston$84K
- Nathaniel AlabiHouston$71K
- Jorge MatukHouston$45K
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.